WOAG
WITHDRAWAL OF ATTORNEY GRANTED
01/11/2025
Back to search
Official data from USPTO
LEATCRT-G2
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
11
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
05/31/2022
Registration date
07/04/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/04/2023
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/13/2022
First use in commerce
05/13/2022
Drawing code
4
Owner type
99
Owner location
Jiangsu, CN
Examiner
MOLINOFF, JEFFREY S.
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Liling biopharmaceuticals (Suzhou) Co., Ltd
Representatives
Liling biopharmaceuticals (Suzhou) Co., Ltd
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Immunostimulants; Biological preparations for the treatment of cancer; Disinfecting wipes; First aid kits; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparationsantivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Tumor suppressing agents
Publications
History of USPTO decisions and trademark events.
11 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
01/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2023
PUBO
PUBLISHED FOR OPPOSITION
04/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2023
DOCK
ASSIGNED TO EXAMINER
03/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2022
NWAP
NEW APPLICATION ENTERED
06/03/2022
Continuous trademark protection
Get notified about every new filing that threatens LEATCRT-G2 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.